Cargando…

Substance abuse in adolescents and young adults : a manual for pediatric and primary care clinicans /

Substance abuse comprises a global biopsychosocial phenomenon for the world as billions of human beings are experimenting with various illicit chemicals and millions are addicted to various substances. By virtue of their complex nature these disorders can be very difficult to treat and not only comp...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Greydanus, Donald E. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Berlin : De Gruyter, 2013.
Colección:Health, medicine, and human development.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBSCO_ocn862809666
003 OCoLC
005 20231017213018.0
006 m o d
007 cr cnu---unuuu
008 131112s2013 gw a ob 001 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d IDEBK  |d EBLCP  |d MHW  |d E7B  |d CDX  |d OCLCQ  |d YDXCP  |d OCLCO  |d OCLCF  |d OCLCQ  |d DEBSZ  |d DEBBG  |d AU@  |d OCLCO  |d AGLDB  |d MOR  |d PIFAG  |d ZCU  |d MERUC  |d OCLCQ  |d DEGRU  |d NZRPM  |d U3W  |d UIU  |d STF  |d VTS  |d ICG  |d VT2  |d TOF  |d OCLCO  |d KOTUI  |d OCLCO  |d OCLCQ  |d WYU  |d OCLCA  |d TKN  |d OCLCO  |d LEAUB  |d DKC  |d OCLCA  |d OCLCQ  |d OCLCO  |d M8D  |d UKAHL  |d UX1  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCLCA  |d VLY  |d AJS  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCA 
016 7 |a 1033298662  |2 DE-101 
016 7 |a 101621232  |2 DNLM 
019 |a 862369519  |a 865063072  |a 880910323  |a 961557245  |a 962565415  |a 1055332304  |a 1065891681  |a 1081238705  |a 1148091594  |a 1162252529  |a 1228570576 
020 |a 9783110311389  |q (electronic bk.) 
020 |a 3110311380  |q (electronic bk.) 
020 |a 9783110311396  |q (print + online) 
020 |a 3110311399  |q (print + online) 
020 |a 1306091888  |q (ebk) 
020 |a 9781306091886  |q (ebk) 
020 |z 9783110313017 
020 |z 3110313014 
024 7 |a 10.1515/9783110311389  |2 doi 
029 1 |a AU@  |b 000052918997 
029 1 |a DEBBG  |b BV042524541 
029 1 |a DEBBG  |b BV043036712 
029 1 |a DEBBG  |b BV043785331 
029 1 |a DEBBG  |b BV044062719 
029 1 |a DEBSZ  |b 423654705 
029 1 |a DEBSZ  |b 431437750 
029 1 |a DEBSZ  |b 434803758 
029 1 |a DEBSZ  |b 472803670 
029 1 |a NZ1  |b 15678399 
035 |a (OCoLC)862809666  |z (OCoLC)862369519  |z (OCoLC)865063072  |z (OCoLC)880910323  |z (OCoLC)961557245  |z (OCoLC)962565415  |z (OCoLC)1055332304  |z (OCoLC)1065891681  |z (OCoLC)1081238705  |z (OCoLC)1148091594  |z (OCoLC)1162252529  |z (OCoLC)1228570576 
037 |a 540439  |b MIL 
050 4 |a RJ506.D78 
060 4 |a 2013 J-966 
060 4 |a WM 270 
072 7 |a RJ  |2 lcco 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 4 |a 616.8600835  |2 23 
049 |a UAMI 
245 0 0 |a Substance abuse in adolescents and young adults :  |b a manual for pediatric and primary care clinicans /  |c edited by Donald E. Greydanus [and three others]. 
264 1 |a Berlin :  |b De Gruyter,  |c 2013. 
300 |a 1 online resource (xxviii, 401 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Health, medicine and human development 
504 |a Includes bibliographical references and index. 
520 |a Substance abuse comprises a global biopsychosocial phenomenon for the world as billions of human beings are experimenting with various illicit chemicals and millions are addicted to various substances. By virtue of their complex nature these disorders can be very difficult to treat and not only complicates the natural course of disease but can also adversely impact long term outcomes. This book is aiming to examine this complex situation in adolescents and young adults and also to provide management plans for clinicians to follow. The information will be presented in an easy to follow format to. 
588 0 |a Print version record. 
505 0 |a Author Index; Foreword; Abbreviations; 1 Introduction: Substance abuse in adolescents and young adults; Section I: Etiology and diagnosis; 2 Neurobiology of substance use disorders; 2.1 Introduction; 2.2 General concepts; 2.2.1 Dopamine; 2.2.2 Serotonin and norepinephrine; 2.2.3 GABA; 2.3 Neuropharmacology of specific drugs; 2.3.1 Stimulants; 2.3.2 Alcohol; 2.3.3 Opioids; 2.3.4 Nicotine/tobacco; 2.3.5 Cannabinoids; 2.4 Summary; 3 Genetic influences on substance abuse disorders; 3.1 Introduction; 3.2 Limitations; 3.3 Gene classes; 3.4 Specific addictions; 3.4.1 Alcohol; 3.4.2 Cannabis. 
505 8 |a 3.4.3 Tobacco3.4.4 Others; 3.5 Epigenetic effects; 3.6 Complex diseases; 3.7 Conclusion; 4 Essential diagnostic considerations; 4.1 Introduction; 4.2 Review of the literature; 4.3 Epidemiology; 4.4 Empirical studies of assessment instruments; 4.5 Comorbidity; 4.6 Assessment; 4.7 Screening; 4.8 Diagnosis; 4.9 Biochemical testing; 4.10 Discussion; Section II: Treatment; 5 Psychosocial treatments for substance use disorders; 5.1 Introduction; 5.2 Motivational treatments; 5.2.1 Precontemplation stage; 5.2.2 Contemplation stage; 5.2.3 Preparation stage; 5.2.4 Action stage; 5.2.5 Maintenance stage. 
505 8 |a 5.2.6 Contemplation of relapse5.3 CM and community reinforcement approaches (CRAs); 5.3.1 CM; 5.3.2 CRA; 5.4 Cognitive behavioral approaches; 5.4.1 Functional analysis; 5.4.2 Drug refusal skills; 5.4.3 RP; 5.5 Family interventions; 5.5.1 Multidimensional family therapy (MDFT); 5.6 Conclusion; 6 General pharmacotherapy principles; 6.1 Introduction; 6.2 Evaluation for pharmacotherapy; 6.3 When is pharmacotherapy appropriate?; 6.4 Conclusion; 7 Use of pharmacological agents for smoking cessation; 7.1 Introduction; 7.2 Epidemiology; 7.3 Chemistry and pharmacology; 7.4 Effects on health. 
505 8 |a 7.5 Behavioral approaches to smoking cessation7.6 Pharmacological agents; 7.6.1 Varenicline; 7.6.2 Bupropion SR; 7.6.3 Nicotine replacement therapies; 7.6.4 Second-line medications; 7.6.5 Vaccine; 7.6.6 E-cigarettes; 7.7 Conclusion; 8 Marijuana: Current concepts and conundrums; 8.1 Introduction; 8.1.1 Cannabis sativa plant; 8.1.2 Prevalence; 8.1.3 Cannabis lab testing; 8.2 Medical adverse effects; 8.2.1 Cannabis hyperemesis; 8.2.2 Dental effects of cannabis; 8.2.3 Pulmonary effects; 8.2.4 Cannabis and cancer; 8.2.5 Cardiovascular effects; 8.2.6 Motor vehicle accidents; 8.2.7 Sports doping. 
505 8 |a 8.2.8 Adverse effects: Psychiatric8.2.9 Management; 8.2.10 Pharmacological therapies; 8.2.11 Cannabis intoxication; 8.2.12 Cannabis withdrawal; 8.3 Cannabis-associated psychosis; 8.3.1 Cannabis dependence; 8.4 Summary; 9 Primary care management of alcohol use disorders of adolescents and young adults; 9.1 Introduction; 9.2 Epidemiology: Drinking patterns and beverage preferences; 9.2.1 Drinking patterns; 9.2.2 Drinking preferences; 9.3 Confidentiality in primary care; 9.4 Screening in primary care; 9.4.1 Screening; 9.4.2 Screening tools; 9.5 Assessment of risk. 
505 8 |a 9.5.1 Screening the college student. 
546 |a English. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Substance abuse  |x Treatment. 
650 0 |a Teenagers  |x Substance use. 
650 0 |a Young adults  |x Substance use. 
650 0 |a Drug abuse. 
650 0 |a Drug addiction. 
650 0 |a Primary health care. 
650 0 |a Primary care (Medicine) 
650 0 |a Young adults. 
650 1 2 |a Substance-Related Disorders 
650 1 2 |a Adolescent 
650 2 2 |a Primary Health Care 
650 2 2 |a Young Adult 
650 6 |a Polytoxicomanie  |x Traitement. 
650 6 |a Adolescents  |x Usage de substances psychoactives. 
650 6 |a Jeunes adultes  |x Usage de substances psychoactives. 
650 6 |a Toxicomanie. 
650 6 |a Soins de santé primaires. 
650 6 |a Jeunes adultes. 
650 7 |a drug addiction.  |2 aat 
650 7 |a drug abuse.  |2 aat 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Young adults.  |2 fast  |0 (OCoLC)fst01183198 
650 7 |a Primary health care.  |2 fast  |0 (OCoLC)fst01076341 
650 7 |a Primary care (Medicine)  |2 fast  |0 (OCoLC)fst01076319 
650 7 |a Drug addiction.  |2 fast  |0 (OCoLC)fst01430217 
650 7 |a Drug abuse.  |2 fast  |0 (OCoLC)fst00898480 
650 7 |a Substance abuse  |x Treatment.  |2 fast  |0 (OCoLC)fst01136830 
650 7 |a Teenagers  |x Substance use.  |2 fast  |0 (OCoLC)fst01145653 
650 7 |a Young adults  |x Substance use.  |2 fast  |0 (OCoLC)fst01183232 
650 7 |a Jugend  |2 gnd 
650 7 |a Drogenmissbrauch  |2 gnd 
650 7 |a Ärztliche Behandlung  |2 gnd 
700 1 |a Greydanus, Donald E.,  |e editor. 
776 0 8 |i Print version:  |t Substance abuse in adolescents and young adults  |z 9783110313017  |w (OCoLC)859526243 
830 0 |a Health, medicine, and human development. 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=661737  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH25314446 
938 |a Coutts Information Services  |b COUT  |n 26589083 
938 |a De Gruyter  |b DEGR  |n 9783110311389 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL1209368 
938 |a ebrary  |b EBRY  |n ebr10811306 
938 |a EBSCOhost  |b EBSC  |n 661737 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n cis26589083 
938 |a YBP Library Services  |b YANK  |n 10818299 
994 |a 92  |b IZTAP